Request Demo
Last update 23 Jan 2025
PBSS-1113
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism USP25 inhibitors(ubiquitin specific peptidase 25 inhibitors), USP28 inhibitors(ubiquitin specific peptidase 28 inhibitors) |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with PBSS-1113CTR20220343
评估PBSS1113治疗复发/难治性急性髓系白血病患者的安全性、耐受性、药代动力学、药效动力学与初步疗效的开放性、剂量递增的I期临床研究试验方案
[Translation] An open-label, dose-escalation Phase I clinical study to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics and preliminary efficacy of PBSS1113 in patients with relapsed/refractory acute myeloid leukemia
ChiCTR2200058683
An open-label, dose-escalating phase I clinical trial to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of PBSS1113 in patients with relapsed/refractory acute myeloid leukemia
100 Clinical Results associated with PBSS-1113
Login to view more data
100 Translational Medicine associated with PBSS-1113
Login to view more data
100 Patents (Medical) associated with PBSS-1113
Login to view more data
100 Deals associated with PBSS-1113
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Refractory acute myeloid leukemia | Phase 1 | CN | 21 Feb 2022 | |
| Relapsing acute myeloid leukemia | Phase 1 | CN | 21 Feb 2022 | |
| Myelodysplastic Syndromes | IND Approval | CN | 15 Oct 2024 | |
| Myeloid Tumor | IND Approval | CN | 15 Oct 2024 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free